Filed: 5/15/2026ACC: 0001013594-26-000605
📋 What this filing means
LION POINT CAPITAL, LP filed this quarterly 13F‑HR report disclosing 35 equity positions with a total reported market value of $16.73M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
35
Positions
$16.73M
Total AUM (reported)
5.75M
Total Shares
Allocation by class
COM$10.67M63.8%
COM NEW$2.85M17.0%
CLASS A ORD$1.26M7.5%
SHS CLASS A$1.03M6.1%
SPONSORED ADS$546.3K3.3%
SHS$240.3K1.4%
ORDINARY SHARES$143.4K0.9%
Portfolio Concentration
Top 3$3.72M22.2%
4–10$5.42M32.4%
11–25$5.75M34.4%
Rest$1.84M11.0%
Top 3 weight
22.2%
Top 10 weight
54.6%
Voting Authority Distribution
Total shares with voting rights: 5.75M
Sole
Full voting authority
5.75M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole35
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings35
Rows:
PRAXIS PRECISION MEDICINES I
SOLEShares4.45K
TypeSH
Market value$1.43M
8.57%
Sole
4.45K
Shared
0.00
None
0.00
MOONLAKE IMMUNOTHERAPEUTICS
SOLEShares67.50K
TypeSH
Market value$1.26M
7.52%
Sole
67.50K
Shared
0.00
None
0.00
ROYALTY PHARMA PLC
SOLEShares21.40K
TypeSH
Market value$1.03M
6.14%
Sole
21.40K
Shared
0.00
None
0.00
MILESTONE PHARMACEUTICALS IN
SOLEShares820K
TypeSH
Market value$975.8K
5.83%
Sole
820K
Shared
0.00
None
0.00
GERON CORP
SOLEShares578K
TypeSH
Market value$861.2K
5.15%
Sole
578K
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares36K
TypeSH
Market value$841.0K
5.03%
Sole
36K
Shared
0.00
None
0.00
ARDELYX INC
SOLEShares128.65K
TypeSH
Market value$770.6K
4.61%
Sole
128.65K
Shared
0.00
None
0.00
FENNEC PHARMACEUTICALS INC
SOLEShares112.43K
TypeSH
Market value$691.5K
4.13%
Sole
112.43K
Shared
0.00
None
0.00
BENITEC BIOPHARMA INC
SOLEShares62K
TypeSH
Market value$660.3K
3.95%
Sole
62K
Shared
0.00
None
0.00
SAREPTA THERAPEUTICS INC
SOLEShares28.50K
TypeSH
Market value$620.2K
3.71%
Sole
28.50K
Shared
0.00
None
0.00
DISC MEDICINE INC
SOLEShares8.10K
TypeSH
Market value$517.9K
3.10%
Sole
8.10K
Shared
0.00
None
0.00
CUE BIOPHARMA INC
SOLEShares2.20M
TypeSH
Market value$506.4K
3.03%
Sole
2.20M
Shared
0.00
None
0.00
COMPASS PATHWAYS PLC
SOLEShares80K
TypeSH
Market value$442.4K
2.64%
Sole
80K
Shared
0.00
None
0.00
BIOHAVEN LTD
SOLEShares51.70K
TypeSH
Market value$437.4K
2.61%
Sole
51.70K
Shared
0.00
None
0.00
LANTHEUS HLDGS INC
SOLEShares5.50K
TypeSH
Market value$417.2K
2.49%
Sole
5.50K
Shared
0.00
None
0.00
JASPER THERAPEUTICS INC
SOLEShares465K
TypeSH
Market value$407.4K
2.44%
Sole
465K
Shared
0.00
None
0.00
HUMACYTE INC
SOLEShares650K
TypeSH
Market value$394.4K
2.36%
Sole
650K
Shared
0.00
None
0.00
VIATRIS INC
SOLEShares27.70K
TypeSH
Market value$374.2K
2.24%
Sole
27.70K
Shared
0.00
None
0.00
KURA ONCOLOGY INC
SOLEShares46K
TypeSH
Market value$374.0K
2.24%
Sole
46K
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares5K
TypeSH
Market value$371.3K
2.22%
Sole
5K
Shared
0.00
None
0.00
DYNE THERAPEUTICS INC
SOLEShares18K
TypeSH
Market value$326.3K
1.95%
Sole
18K
Shared
0.00
None
0.00
ROCKET PHARMACEUTICALS INC
SOLEShares86K
TypeSH
Market value$307.9K
1.84%
Sole
86K
Shared
0.00
None
0.00
PACIRA BIOSCIENCES INC
SOLEShares13.50K
TypeSH
Market value$305.1K
1.82%
Sole
13.50K
Shared
0.00
None
0.00
EDGEWISE THERAPEUTICS INC
SOLEShares9.10K
TypeSH
Market value$286.6K
1.71%
Sole
9.10K
Shared
0.00
None
0.00
MINERALYS THERAPEUTICS INC
SOLEShares10.50K
TypeSH
Market value$284.4K
1.70%
Sole
10.50K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
PRAXIS PRECISION MEDICINES ISOLE | COM NEW | 4.45K | SH | $1.43M 8.57% | 4.45K | 0.00 | 0.00 |
MOONLAKE IMMUNOTHERAPEUTICSSOLE | CLASS A ORD | 67.50K | SH | $1.26M 7.52% | 67.50K | 0.00 | 0.00 |
ROYALTY PHARMA PLCSOLE | SHS CLASS A | 21.40K | SH | $1.03M 6.14% | 21.40K | 0.00 | 0.00 |
MILESTONE PHARMACEUTICALS INSOLE | COM | 820K | SH | $975.8K 5.83% | 820K | 0.00 | 0.00 |
GERON CORPSOLE | COM | 578K | SH | $861.2K 5.15% | 578K | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 36K | SH | $841.0K 5.03% | 36K | 0.00 | 0.00 |
ARDELYX INCSOLE | COM | 128.65K | SH | $770.6K 4.61% | 128.65K | 0.00 | 0.00 |
FENNEC PHARMACEUTICALS INCSOLE | COM | 112.43K | SH | $691.5K 4.13% | 112.43K | 0.00 | 0.00 |
BENITEC BIOPHARMA INCSOLE | COM NEW | 62K | SH | $660.3K 3.95% | 62K | 0.00 | 0.00 |
SAREPTA THERAPEUTICS INCSOLE | COM | 28.50K | SH | $620.2K 3.71% | 28.50K | 0.00 | 0.00 |
DISC MEDICINE INCSOLE | COM | 8.10K | SH | $517.9K 3.10% | 8.10K | 0.00 | 0.00 |
CUE BIOPHARMA INCSOLE | COM | 2.20M | SH | $506.4K 3.03% | 2.20M | 0.00 | 0.00 |
COMPASS PATHWAYS PLCSOLE | SPONSORED ADS | 80K | SH | $442.4K 2.64% | 80K | 0.00 | 0.00 |
BIOHAVEN LTDSOLE | COM | 51.70K | SH | $437.4K 2.61% | 51.70K | 0.00 | 0.00 |
LANTHEUS HLDGS INCSOLE | COM | 5.50K | SH | $417.2K 2.49% | 5.50K | 0.00 | 0.00 |
JASPER THERAPEUTICS INCSOLE | COM NEW | 465K | SH | $407.4K 2.44% | 465K | 0.00 | 0.00 |
HUMACYTE INCSOLE | COM | 650K | SH | $394.4K 2.36% | 650K | 0.00 | 0.00 |
VIATRIS INCSOLE | COM | 27.70K | SH | $374.2K 2.24% | 27.70K | 0.00 | 0.00 |
KURA ONCOLOGY INCSOLE | COM | 46K | SH | $374.0K 2.24% | 46K | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | COM | 5K | SH | $371.3K 2.22% | 5K | 0.00 | 0.00 |
DYNE THERAPEUTICS INCSOLE | COM | 18K | SH | $326.3K 1.95% | 18K | 0.00 | 0.00 |
ROCKET PHARMACEUTICALS INCSOLE | COM | 86K | SH | $307.9K 1.84% | 86K | 0.00 | 0.00 |
PACIRA BIOSCIENCES INCSOLE | COM | 13.50K | SH | $305.1K 1.82% | 13.50K | 0.00 | 0.00 |
EDGEWISE THERAPEUTICS INCSOLE | COM | 9.10K | SH | $286.6K 1.71% | 9.10K | 0.00 | 0.00 |
MINERALYS THERAPEUTICS INCSOLE | COM | 10.50K | SH | $284.4K 1.70% | 10.50K | 0.00 | 0.00 |
Page 1 of 2